Astrana Health (NASDAQ:ASTH) Cut to Hold at Wall Street Zen

Wall Street Zen lowered shares of Astrana Health (NASDAQ:ASTH) from a buy rating to a hold rating in a research note published on Sunday morning.

Other equities research analysts have also recently issued reports about the stock. TD Cowen boosted their price target on shares of Astrana Health from $45.00 to $50.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Barclays boosted their target price on Astrana Health from $50.00 to $53.00 and gave the company an “overweight” rating in a report on Friday, August 7th. BTIG Research lifted their price target on Astrana Health from $50.00 to $65.00 and gave the stock a “buy” rating in a research report on Tuesday, July 14th. Needham & Company LLC boosted their price objective on Astrana Health from $30.00 to $41.00 and gave the company a “buy” rating in a research note on Friday, May 8th. Finally, Robert W. Baird set a $45.00 price objective on Astrana Health in a report on Friday, May 8th. Seven investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $49.43.

Astrana Health Stock Down 1.5%

Astrana Health stock opened at $39.16 on Friday. The stock’s fifty day moving average is $41.39 and its two-hundred day moving average is $33.12. The stock has a market cap of $2.18 billion, a PE ratio of 47.76 and a beta of 0.87. Astrana Health has a 1-year low of $18.08 and a 1-year high of $51.60. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.23 and a quick ratio of 1.23.

Astrana Health (NASDAQ:ASTH) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.80 EPS for the quarter, beating analysts’ consensus estimates of $0.34 by $0.46. The business had revenue of $972.52 million for the quarter, compared to the consensus estimate of $985.62 million. Astrana Health had a return on equity of 10.30% and a net margin of 1.05%.The business’s revenue for the quarter was up 48.5% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.19 EPS. On average, sell-side analysts expect that Astrana Health will post 1.31 EPS for the current fiscal year.

Hedge Funds Weigh In On Astrana Health

A number of hedge funds and other institutional investors have recently made changes to their positions in ASTH. 325 Capital LLC lifted its holdings in shares of Astrana Health by 54.0% during the fourth quarter. 325 Capital LLC now owns 1,839,076 shares of the company’s stock worth $45,627,000 after purchasing an additional 645,123 shares during the period. Wellington Management Group LLP increased its stake in Astrana Health by 418.3% in the 4th quarter. Wellington Management Group LLP now owns 738,853 shares of the company’s stock valued at $18,331,000 after buying an additional 596,293 shares during the period. Diamond Hill Capital Management LLC Investment Advisor acquired a new position in Astrana Health in the 2nd quarter valued at $22,088,000. Ameriprise Financial Inc. raised its position in Astrana Health by 231.0% during the 3rd quarter. Ameriprise Financial Inc. now owns 442,314 shares of the company’s stock worth $12,540,000 after buying an additional 308,665 shares during the last quarter. Finally, Bank of New York Mellon Corp purchased a new position in Astrana Health during the 2nd quarter worth $10,902,000. Hedge funds and other institutional investors own 52.77% of the company’s stock.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.